# HIGHLINE CAPITAL MANAGEMENT, L.P.

> Institutional holdings reported to the SEC as of Q3 2022 on Form 13F. CIK 1166850. Source: https://holderbook.com/funds/1166850-highline-capital-management-l-p/

- Reported value: $53.5M
- Positions: 15
- Weight of the ten largest: 87.3%
- Filed: 2022-11-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| UNITEDHEALTH GROUP INC | [UNH](https://holderbook.com/stocks/UNH/) | $9.3M | 18,465 | 17.4% | 4 |
| ALGOMA STL GROUP INC | [ASTL](https://holderbook.com/stocks/ASTL/) | $5.2M | 809,010 | 9.7% | 4 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $5.1M | 45,040 | 9.5% | 11 |
| BWX TECHNOLOGIES INC | [BWXT](https://holderbook.com/stocks/BWXT/) | $5.0M | 99,523 | 9.4% | 1 |
| GRAY MEDIA INC | [GTN](https://holderbook.com/stocks/GTN/) | $5.0M | 348,697 | 9.3% | 1 |
| MICROSOFT CORP | [MSFT](https://holderbook.com/stocks/MSFT/) | $4.8M | 20,700 | 9.0% | 1 |
| MOSAIC CO | [MOS](https://holderbook.com/stocks/MOS/) | $3.7M | 76,049 | 6.9% | 2 |
| AVANTOR INC | [AVTR](https://holderbook.com/stocks/AVTR/) | $3.4M | 175,113 | 6.4% | 11 |
| EDAP TMS S A | [FOCL](https://holderbook.com/stocks/FOCL/) | $2.8M | 333,333 | 5.1% | 1 |
| MARKETWISE INC | [MKTW](https://holderbook.com/stocks/MKTW/) | $2.4M | 1,060,853 | 4.5% | 5 |
| TAKEDA PHARMACEUTICAL CO LTD | [TAK](https://holderbook.com/stocks/TAK/) | $1.9M | 0 | 3.6% | 1 |
| ARCELORMITTAL SA LUXEMBOURG | [MT](https://holderbook.com/stocks/MT/) | $1.9M | 94,007 | 3.5% | 3 |
| PASSAGE BIO INC | [PASG](https://holderbook.com/stocks/PASG/) | $1.5M | 1,235,869 | 2.9% | 11 |
| ATAI LIFE SCIENCES NV | [ATAI](https://holderbook.com/stocks/ATAI/) | $1.0M | 309,680 | 1.9% | 4 |
| ALGOMA STL GROUP INC | [ASTLW](https://holderbook.com/stocks/ASTLW/) | $390.0K | 406,027 | 0.7% | 4 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q3 2022 | -16.8% | -5.3% | -11.5% | 100% |
| Q2 2022 | -25.4% | -16.5% | -9.0% | 100% |
| Q1 2022 | +3.5% | -4.9% | +8.4% | 97% |
| Q4 2021 | -5.6% | +10.7% | -16.3% | 89% |
| Q3 2021 | -12.1% | +0.3% | -12.4% | 97% |
| Q2 2021 | -2.2% | +8.0% | -10.2% | 100% |
| Q1 2021 | -6.6% | +6.0% | -12.6% | 95% |
| Q4 2020 | +13.9% | +11.6% | +2.2% | 93% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2022 | $53.5M | 15 |
| Q2 2022 | $57.9M | 13 |
| Q1 2022 | $82.4M | 12 |
| Q4 2021 | $113.5M | 14 |
| Q3 2021 | $118.4M | 14 |
| Q2 2021 | $119.8M | 14 |
| Q1 2021 | $146.7M | 16 |
| Q4 2020 | $204.4M | 24 |
| Q3 2020 | $99.9M | 16 |
| Q2 2020 | $123.0M | 19 |
| Q1 2020 | $410.7M | 25 |
| Q4 2019 | $631.3M | 22 |

